IRIX insider trading
NasdaqCM HealthcareIRIDEX CORP: insider trade history from SEC Form 4 filings.
About IRIDEX CORP
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. In addition, it offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform transscleral laser therapy; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products that are used for endophotocoagulation. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics through direct and independent sales force in the United States, as well as through independent distributors internationally. It operates in the United States, Europe, the Middle East, Africa, the Asia/Pacific region, and the Americas. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.
Company website: www.iridex.com
IRIX insider activity at a glance
FilingIQ tracks 491 insider transactions for IRIX in filings since Jan 14, 2015. The most recent transaction is dated Oct 1, 2026.
Across the full history, 206 open-market purchases
and 59 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on IRIX insider trades is 48.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest IRIX Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for IRIX?
- FilingIQ tracks 491 Form 4 insider transactions for IRIX (IRIDEX CORP), covering filings from Jan 14, 2015 onwards. 8 of those are dated within the last 90 days.
- Are IRIX insiders net buyers or net sellers?
- Across the full Form 4 history for IRIX, 206 transactions (42%) were open-market purchases and 59 (12%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does IRIX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is IRIX in?
- IRIDEX CORP (IRIX) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $24.65M.
Methodology & sources
Every IRIX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.